bit.bio is a series b startup based in United Kingdom. 1 investor tracked.
Based in the United Kingdom, bit.bio is a startup founded in 2017. Its most recent tracked round is Series B. Brouky records 4 investors associated with the company.
bit.bio programs cells for new medicines. The company's opti-ox technology enables precise, consistent and scalable manufacturing of human cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.